{"cdcTestId":"2013-0344","testcaseName":"Dose 2 to 3, interval 8 weeks -4 days, #3 after 12 months of age","vaccineGroup":"HIB","evaluationTestType":"All Valid: Forecast Test","forecastTestType":"Not recommended: series complete","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"2021-09-12T00:00:00","gender":"F"},"evaluation":{"seriesStatus":"Complete","administeredDoses":[{"dateAdministered":"2021-11-12T00:00:00","vaccineName":"ACTHIB","cvx":"48","mvx":"PMC","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-08-26T00:00:00","vaccineName":"PEDVAXHIB","cvx":"49","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-17T00:00:00","vaccineName":"PEDVAXHIB","cvx":"49","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null}]},"forecast":{"forecastNum":"-","earliestDate":"0001-01-01T00:00:00","recommendedDate":"0001-01-01T00:00:00","pastDueDate":"0001-01-01T00:00:00"},"doses":[{"dateAdministered":"2021-11-12T00:00:00","vaccineName":"ACTHIB","cvx":"48","mvx":"PMC","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-08-26T00:00:00","vaccineName":"PEDVAXHIB","cvx":"49","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-17T00:00:00","vaccineName":"PEDVAXHIB","cvx":"49","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null}],"dateAdded":"2013-01-01T00:00:00","dateUpdated":"2020-05-27T15:31:15.596","generalDescription":"This test case describes when a child greater than 12 months of age is administered a third dose of the Hib vaccine at an interval of 8 weeks - 4 days from the second dose that the dose is valid.  No further doses should be forecast.  The series is complete.","changedInVersion":"1.0","reasonForChange":""}